Showing results (161-170 of 195) with videos related to
Sort By:
Pageof 20
Transplantation|October 6, 1997
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectinW W Hancock, T Miyatake, N Koyamada, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1993
CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokinesJ W Kupiec-Weglinski, B Wasowska, I Papp, et al.The Journal of Clinical Investigation|March 11, 2000
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritisJ Reynolds, F W Tam, A Chandraker, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant modelL V Riella, T Liu, J Yang, et al.The Journal of Clinical Investigation|April 4, 2001
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4D A Mandelbrot, M A Oosterwegel, K Shimizu, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipientsK Onodera, W W Hancock, E Graser, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2002
Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndromeS I Reznik, A Jaramillo, K S SivaSai, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responsesK Onodera, A Chandraker, M Schaub, et al.The Journal of Clinical Investigation|March 17, 1999
Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosisB Murphy, C C Magee, S I Alexander, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathyR S Lee, K Yamada, S L Houser, et al.Pageof 20